Emmanuelle Charpentier of the Max Planck Institute was a joint winner of the international 2016 Tang Prize for Biopharmaceutical Science. She won the award-along with Jennifer A. Doudna and Feng Zhang-for "the development of CRISPR/Cas9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment." Winners of the prestigious honor receive a $1.3 million cash prize and $330,000 in grants toward their research project. Since 2015, Tang Prize Biopharmaceutical Science laureates have presented their award lectures at Experimental Biology (EB).
展开▼
